Eli Lily, Summit Therapeutics and Vertex Pharmaceuticals have important current clinical trials. The shares of these drug manufacturers can jump if the studies are positive. All three companies have attractive prospects beyond that. 10 shares we like better than Eli Lily › Few things can discard the pharmaceutical company shares as a positive results from … Read more
The shares listed here have increased their payments with dividends by more than 10% recently. Although their yields may seem imperceptible, they increase their high prices payments. They all do well this year and their prospects for growth remain encouraging. 10 shares we like better than Eli Lily › When you think of a large … Read more
Hims & Hers (Hims) shares fell nearly 35% on Monday after Novo Nordisk (NVO) announced that it was completing the cooperation to make its weakened blockbuster medicine, Wegov, available on the Hims Tele leaf. Novo Nordisk said Hims & Her violates the law by continuing to sell Copycat semaglutide, the key ingredient in Wegovy, along … Read more
Hims & Hers (Hims) shares fell about 30% in early trade on Monday after Novo Nordisk (NVO) announced that it ended the cooperation to make its weakening drug, Wegovy, available on the Hims Hims platform. Novo Nordisk said Hims & Her violates the law by continuing to sell Copycat semaglutide, the key ingredient in Wegovy, … Read more